|
CHOLESTEROL:
A PATIENT-SPECIFIC
NUTRITIONAL
APPROACH
by
Guy R. Schenker, D.C.
(This
article has been published by: Today's Chiropractic March/April
1989, and by Healthcare Rights Advocate June, 1990, the Journal of
the Coalition for Alternatives in Nutrition and Healthcare.)
INTRODUCTION
When asked how he had been so
successful in blazing a new path of thought Einstein replied, "I did it
solely by challenging axioms." It is the intent of this article to
challenge the universally accepted idea that dietary intake of cholesterol
is correlated directly with cholesterolemia and with myocardial
infarction. A patient-specific approach to the problem of
hypercholesterolemia and coronary artery disease is offered.
An axiom, though based upon scientifically verifiable facts, is not itself
provable. In other words, an axiom is an extrapolation of the facts, i.
e.; it involves "jumping to conclusions." From certain scientifically
measurable facts it was once axiomatically accepted that the earth was
flat and the sun revolved around the earth. An extrapolation of facts
always involves making assumptions; assumptions which in this case clearly
were inaccurate.
A statistically significant correlation between hypercholesterolemia and
myocardial infarction has been demonstrated. From this irrefutable fact it
is accepted as self-evident the assumption that dietary cholesterol intake
leads to elevated cholesterol and thence to heart attack. It must be
understood that this is indeed an assumption. Nowhere, to the author's
knowledge, has a cause and effect relationship been established between
cholesterol intake and either cholesterolemia or atherosclerosis.
If high cholesterol and cardiovascular disease do not result from eating
cholesterol, then where do they come from? Numerous studies have shown
that it is aberrant lipid metabolism, not over-consumption, that causes
cholesterol problems. This knowledge allows the clinical nutritionist to
approach patients with something more than advice to quit eating
cholesterol. By specific testing, the metabolic imbalance that has
deranged lipid metabolism in each individual patient can be identified.
Having defined the individual's underlying biochemical imbalances, the
clinician can prescribe a specific nutrition regimen designed to restore
normal metabolism, rather than treating high cholesterol as a disease
entity per se. It is thus possible to correct the cause of the problem,
more than merely minimizing its effects.
RESEARCH REFUTING THE CHOLESTEROL AXIOM
Following are a number of little known facts regarding cholesterol which
are in direct conflict with commonly accepted assumptions.
Cholesterol is a requirement of every living cell and we cannot live
without it. It is the building block of sex hormones. Fifteen percent of
the dry weight of the human brain is cholesterol (5, 9).
The body synthesizes 2,000 mg. daily of this essential substance. In
comparison, even a high cholesterol diet provides only about 800 mg.
Furthermore, when large quantities of cholesterol are ingested the body
simply synthesizes less such that an excess is avoided. Animal studies
which induced atheroma with dietary cholesterol used the human equivalent
of 15,000 mg. of cholesterol a day (1).
Animals fed a diet consisting of 81% animal fat, but with concurrent high
levels of protein, vitamins and minerals showed no pathological changes in
the aorta or the heart (2, 8).
Studies of primitive African cultures have shown no correlation between
dietary intake and atherosclerosis even among 400 men of the Masai tribe
who ate meat and milk exclusively. A strong correlation does exist,
however, between atherosclerosis and consumption of refined sugar and
flour (6, 7).
In 1914 only 15% of all heart disease was atherosclerotic in nature; today
that has risen to over 90%. Over 50% of adult Americans now die of
cardiovascular disease. Yet the only significant change in dietary
patterns in Western countries over the last 100 years has not been in fat
consumption but in refined sugar and flour intake (15).
Hundreds of millions of dollars have been spent on research attempting to
prove that eating foods high in cholesterol increases the risk of heart
attack. No such evidence has been produced (3).
Even the existence of a statistical correlation between hyper-
cholesterolemia and myocardial infarction does not necessarily establish a
cause and effect relationship. How do we explain the countless patients in
our practices whose x-rays show arteriosclerosis of the aorta, yet who
have normal serum cholesterol? How do we explain the patients who have
cholesterol levels over 300 yet show no evidence of cardiovascular
disease? How do we explain to the heart attack victim with normal
cholesterol that he is a statistical fluke?
To conclude, based on epidemiological studies, that serum cholesterol and
heart attack are cause and effect seems a careless assumption. But to
extrapolate from those statistics that dietary cholesterol causes
cardiovascular disease represents a rather blatant "jumping to
conclusions."
UNDERSTANDING HYPERCHOLESTEROLEMIA
So what does it actually mean when a patient has high serum cholesterol?
The answer to this question lies in a study not of cholesterol, but of the
individual and his or her unique body chemistry. Hypercholesterolemia is
merely a symptom arising from one of two possible underlying metabolic
imbalances.
Nutri-Spec has developed the means by which a clinician can obtain
complete evaluation of a patient's body chemistry using objective test
procedures. Urine and saliva chemistries as well as clinical tests are
employed in identifying the patient’s metabolic imbalances (11). The Nutri-Spec
system represents a radical departure from disease-specific methods of
diagnosis and treatment, in favor of a purely patient-specific approach.
Nutri-Spec has defined five fundamental metabolic balance systems, the
operations of which are involved in maintaining homeostasis of all
physiological processes. All pathology reflects a loss of homeostasis
associated with aberration in one or more of the five fundamental balances
(12). Every patient's symptoms, therefore, have a nutrition component and
will benefit from restoration of metabolic balance (13, 14).
When studied in this light, atherosclerosis is seen as a dysfunction in
two of the fundamental balances, namely, water/electrolyte balance and
anaerobic/dysaerobic balance. While a discussion of water/electrolyte
balance lies outside the theme of this article, anaerobic/dysaerobic
imbalance fully explains the vast majority of high cholesterol problems.
Anaerobic/dysaerobic balance concerns not only the problems of oxidative
energy production, but also represents the two opposite abnormalities of
lipid metabolism. An anaerobic patient has insufficient fatty acid
activity and excess sterols; the dysaerobic patient has excess fatty acids
and insufficient sterols.
Cholesterol is a sterol fat. An excess, therefore, represents an anaerobic
imbalance, while low levels correspond to a dysaerobic condition. However,
there is a vital fact about cholesterol of which most are not cognizant;
its biological role is played only at the cellular level. This means that
serum cholesterol levels say absolutely nothing about a patient's
cholesterol status (10).
Hypercholesterolemic patients can be either anaerobic or dysaerobic. If
anaerobic, their cells are so saturated with cholesterol that it has now
begun to accumulate in the serum. A dysaerobic patient actually has low
cellular cholesterol due to excess fatty acid activity there. Serum levels
rise as the cholesterol is unable to penetrate the cells.
Clinically this means that there is no treatment for high cholesterol per
se. Effective therapy is contingent upon determining the patient's
fundamental biochemical imbalance. Having done so, the clinician can
confidently prescribe the diet and supplements specific to the individual
patient's needs.
The anaerobic patient responds to one or more of the following
supplements: negative valence sulfur, vitamin B6, magnesium (orotate or
aspartate), L-carnitine, copper, and proteolytic enzymes (bromelaine,
pancreatin). Dietary recommendations include avoidance of sugar, alcohol,
fermented foods, and sterol fats.
If dysaerobic, the patient's supplemental needs will be met from the
following: glycerol, choline, inositol, potassium (orotate or citrate),
bioflavenoids, and niacin. The diet must avoid free fatty acids and trans
fatty acids (vegetable oils, margarine, salad dressing, fried foods,
canned meats), and include sterol fats (--- Yes, the diet must include
high-cholesterol foods such as eggs).
CASE HISTORY
A 45-year old male presented with serum cholesterol of 324, and a blood
pressure of 138/94. Nutri-Spec testing revealed a dysaerobic imbalance as
well as a water/ electrolyte imbalance. He was put on a salt restricted
diet and supplemented with mineral dispersing agents for his
water/electrolyte imbalance. Being dysaerobic, he was given the
appropriate diet and supplementation.
In five weeks his cholesterol had dropped to 184. His blood pressure had
dropped to 121/77.
This case history reiterates our point that there is no disease-specific
nutrition treatment for hypercholesterolemia. The patient was treated not
for his disease, but per his biochemical imbalances. His cholesterol,
being merely an effect of underlying causes, responded dramatically when
those causes were corrected.
SUMMARY
Objective clinical testing procedures are the only consistently
efficacious means to implement patient-specific diagnosis and treatment.
The familiar cliche' applies, "We must treat the patient and not the
disease."
This statement of traditional wisdom could not be more true of
hypercholesterolemia. Routine prescription of a low cholesterol diet and
not much else is woefully inadequate case management, and allows what is a
reversible condition to progress to the stage of life threatening tissue
degeneration.
The cholesterol axiom stands without foundation. The true causative
factors of hypercholersterolemia can be reliably determined and
effectively treated.
REFERENCES
1) Anitschow, N: "Changes in the Rabbit Aorta in Experimental Cholesterol
Steatose," Beitr Pathol Anat 56; 379-404, 1913.
2) Barboriak, J J: "Influence of High-fat Diets; Growth and Development of
Obesity in the Albino Rat," J Nutr 64: 241-249, 1958.
3) Bundlie, E: "Egg Nutrition Group Has Active First Year,"
Feedstuffs
Sept. 11,1972, p 21.
4) Cabot, R C: "The Four Common Types of Heart Disease,"
JAMA 63:
1461-1463, 1914.
5) Clausen, J: "Gray-White Matter Differences," Handbook of
Neurochemistry, Vol 1. edited by Lajtha. New York, Plenum, 1969, 273-300.
6) Cleave, TL: "The Saccharine Disease," Bristol, John Write & Sons, 1974.
7) Mann, G V, Shaffer, R D: "Cardiovascular Disease in the Masai,"
Atheroslerosis Res 4:289-312, 1964.
8) Naimi, S "Cardiovascular Lesions, Blood Lipids, Coagualation and
Fibrinolysis in Butter-induced Obesity in the Rat," J Nutr 86: 325-332.
1965.
9) National Commission on Egg Nutrition, Eggs and Cholesterol, A position
paper, Chicago, 1972.
10) Revici, E: "Research in Physiopathology as a Basis of Guided
Chemotherapy," 453-457, New York 1961.
11) Schenker, GR: "Nutritional Specificity and Laboratory Testing, Part
I, "Digest of Chiropractic Economics, Vol. 27, Number 1,
July/August, 1984.
12) Schenker, GR: "Nutritional Specificity and Laboratory Testing, Part
II," Digest of Chiropractic Economics, Vol. 27, Number 1,
July/August, 1984.
13) Schenker, GR: "Pain Control: A Specific Nutritional Approach,"
Digest of Chiropractic Economics, Vol. 28, Number 3, Nov/Dec,
1985.
14) Schenker, GR: " Nutrition for Athletes: Anabolic and Erogenic,"
Digest of Chiropractic Economics, Vol. 30, Number 3, Nov/Dec,
1987.
15) Yudkin, J: "Sugar Consumption and Myocardial Infarction,"
Lancet 1: 296-297, 1971.
|